Bretylium Tosylate Injection while Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Bretylium Tosylate Injection for its safety in breastfeeding.

What is Bretylium Tosylate Injection used for?


Bretylium Tosylate Injection, USP is indicated in the prophylaxis and therapy of ventricular fibrillation. Bretylium Tosylate Injection, USP is also indicated in the treatment of life-threatening ventricular arrhythmias, such as ventricular tachycardia that have failed to respond to adequate doses of a first-line antiarrhythmic agent, such as lidocaine. Use of Bretylium Tosylate Injection, USP should be limited to intensive care units, coronary care units or other facilities where equipment and personnel for constant monitoring of cardiac arrhythmias and blood pressure are available. Following injection of bretylium tosylate there may be a delay of 20 minutes to 2 hours in the onset of antiarrhythmic action, although it appears to act within minutes in ventricular fibrillation. The delay in effect appears to be longer after intramuscular than after intravenous injection.

I am breastfeeding mother and I am using Bretylium Tosylate Injection. Can it have any bad effect on my kid? Shall I search for better alternative?

Bretylium Tosylate Injection contains Bretylium tosylate as active ingredients, . We do not have safety rating of Bretylium tosylate but we do have analysis of Bretylium tosylate, which is used in manufacturing of Bretylium Tosylate Injection. You can get a good idea about Bretylium Tosylate Injection usage while breastfeeding by going through our detailed analysis as below.

Bretylium Tosylate Injection Breastfeeding Analsys


Bretylium tosylate while Breastfeeding

CAS Number: 59-41-6

Because there is little published experience with bretylium during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant. It has low oral bioavailability, so older infants are unlikely to absorb it. Exclusively breastfed infants should be carefully monitored if this drug is used during lactation, possibly including measurement of serum levels to rule out toxicity if there is a concern.


Bretylium Tosylate Injection and breastfeeding

I already used Bretylium Tosylate Injection and meanwhile I breastfed my baby should I be concerned?

We are not completely sure about safety of Bretylium Tosylate Injection in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Bretylium Tosylate Injection. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


I am nursing mother and my doctor has suggested me to use Bretylium Tosylate Injection, is it safe?

If your doctor considers Bretylium Tosylate Injection safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Bretylium Tosylate Injection, will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Bretylium Tosylate Injection in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week